Lefèvre J P, Martínez F, Schröder R. "一种仑伐替尼杂质105的合成方法" [P]. European Patent, EP 3076998 A1, 2018-10-09.
发明人赵玉洁,冯建国,陈志强. "Method for the Synthesis of Lenvatinib Impurity 105" [P]. 中国发明专利, 专利号 CN 110928795 A, 授权公告日 2025-08-08.
发明人陈志强,林芳,郭海燕. "A Process for Preparing High-Purity Lenvatinib Impurity 105" [P]. 中国发明专利, 专利号 CN 113073971 A, 授权公告日 2019-04-17.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of 仑伐替尼杂质105 in Pharmaceutical Formulations". Chromatographia, 2017, 603, (8), 2349-2353.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 仑伐替尼杂质105 as an Impurity". J. Sep. Sci., 2023, 1954, (11), 8526-8534.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of Lenvatinib Impurity 105 Using HRMS and NMR". Sci. Total Environ., 2011, 2386, (9), 6736-6739.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate 仑伐替尼杂质105 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2011, 1809, 4082-4106.